These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26711540)

  • 1. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.
    Patrick ME; O'Malley PM; Kloska DD; Schulenberg JE; Johnston LD; Miech RA; Bachman JG
    Drug Alcohol Rev; 2016 Sep; 35(5):586-90. PubMed ID: 26711540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
    Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
    J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
    Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
    Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana.
    Clayton HB; Lowry R; Ashley C; Wolkin A; Grant AM
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28289138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bath salts and polyconsumption: in search of drug-drug interactions.
    Lopez-Rodriguez AB; Viveros MP
    Psychopharmacology (Berl); 2019 Mar; 236(3):1001-1014. PubMed ID: 30911791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the 'bath salt' panic: the rarity of synthetic cathinone use among students in the United States.
    Stogner JM; Miller BL
    Drug Alcohol Rev; 2013 Sep; 32(5):545-9. PubMed ID: 23718639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New psychoactive substances and their prevalence in the Czech Republic].
    Mravčík V; Běláčková V; Grohmannová K; Zábranský T
    Cas Lek Cesk; 2015; 154(5):216-21. PubMed ID: 26612328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
    Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM
    Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Flakka" use among high school seniors in the United States.
    Palamar JJ; Rutherford C; Keyes KM
    Drug Alcohol Depend; 2019 Mar; 196():86-90. PubMed ID: 30709657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of substance use among urban adolescents: questionnaire study.
    Ljubotina D; Galić J; Jukić V
    Croat Med J; 2004 Feb; 45(1):88-98. PubMed ID: 14968461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.
    Helander A; Beck O; Hägerkvist R; Hultén P
    Scand J Clin Lab Invest; 2013 Aug; 73(5):400-6. PubMed ID: 23692208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
    Strube J; Schaper A
    Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):684-692. PubMed ID: 29404633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicology and management of novel psychoactive drugs.
    Kersten BP; McLaughlin ME
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones ("Bath Salts") in Recreational Users.
    Ashrafioun L; Bonadio FA; Baik KD; Bradbury SL; Carhart VL; Cross NA; Davis AK; Feuille M; Harper AR; Lackey JH; Lang B; Lauritsen KJ; Leith J; Osborn LA; Rosenberg H; Stock J; Zaturenskaya M
    J Psychoactive Drugs; 2016; 48(5):336-343. PubMed ID: 27681583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic cannabinoid use in a nationally representative sample of US high school seniors.
    Palamar JJ; Acosta P
    Drug Alcohol Depend; 2015 Apr; 149():194-202. PubMed ID: 25736618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory comparative study on the diffusion of synthetic cannabinoids and synthetic cathinones.
    Arfken CL; Owens D; Madeja C; DeAngelis C
    J Psychoactive Drugs; 2014; 46(5):362-8. PubMed ID: 25364986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
    Champion KE; Teesson M; Newton NC
    Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.